Same Indication

Pacritinib Citrate vs Tofacitinib

Pacritinib Citrate vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Pacritinib Citrate and Tofacitinib.

Mechanism of Action

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Tofacitinib β€” 3.2 hours.

Chemical Properties

Molecular Formula: Tofacitinib β€” C16H20N6O.

Molecular Weight: Tofacitinib β€” 312.3700 g/mol.

Type: Pacritinib Citrate β€” Small molecule; Tofacitinib β€” Small molecule.